Hyperphosphatemia

Dietary Interventions Improve Hyperphosphatemia Treatment

Dietary Interventions Improve Hyperphosphatemia Treatment

By

Cutting back on dietary phosphorus in addition to taking phosphate binders achieved greater decreases in serum phosphate in PD patients.

Many Beverages Contain Hidden Phosphorus

Many Beverages Contain Hidden Phosphorus

By

A study found that 78% of popular drinks, from flavored waters to lemonades to iced teas, contain far more phosphorus than listed in nutritional databases.

Phosphorus, Calcium Decreases Linked to Improved HD Patient Survival

Phosphorus, Calcium Decreases Linked to Improved HD Patient Survival

By

Lowest relative risk of death observed in patients with serum phosphorus and calcium levels of 4.4 mg/dL and 8.8 mg/dL, respectively.

Uncontrolled Hyperphosphatemia Linked to Herbal, Dietary Supplements

Uncontrolled Hyperphosphatemia Linked to Herbal, Dietary Supplements

By

Patients who use the supplements should have their kidney function and electrolytes monitored, researchers say.

Adverse Events Common During Continuous Renal Replacement Therapy

Adverse Events Common During Continuous Renal Replacement Therapy

By

In a study, the incidence of hyperphosphatemia, ionized hypocalcemia, and ionized hypercalcemia was 44%, 22%, and 23%, respectively.

Iron-Based Binder Could Improve Adherence

Iron-Based Binder Could Improve Adherence

By

It had a phosphorus-lowering effect similar to that of sevelamer, but had a lower pill burden.

Non-Dialysis CKD-MBD Care Suboptimal

Non-Dialysis CKD-MBD Care Suboptimal

By

One-third of patients who missed clinical targets for phosphorus, calcium and/or parathormone remained untreated.

Phosphorus Control Linked to Self-Motivation in ESRD

Phosphorus Control Linked to Self-Motivation in ESRD

By

Strategies to overcome motivational barriers may improve mineral bone health.

Phosphate Binders Cut Mortality, Up ESRD Risk

Phosphate Binders Cut Mortality, Up ESRD Risk

By

These findings underscore the need to better understand whether earlier phosphorus management influences morbidity and mortality in advanced CKD, according to researchers.

Understanding Patient Beliefs May Aid Phosphorus Control

Understanding Patient Beliefs May Aid Phosphorus Control

By

Individuals who perceived the benefits of a low-phosphorus diet and demonstrated self-efficacy were more likely to make strides against hyperphosphatemia.

Phosphorus Pyramid for CKD Provides Diet Advice

Phosphorus Pyramid for CKD Provides Diet Advice

By

Reducing dietary phosphorus is challenging, so researchers have developed a food pyramid for CKD and dialysis patients.

Higher Phosphorus Levels Linked to Mortality

Higher Phosphorus Levels Linked to Mortality

By

The findings generally support KDOQI guidelines for dialysis patients, which recommend maintaining serum phosphorus levels between 3.5 and 5.5 mg/dL.

25+ Low-Potassium Plant Foods

25+ Low-Potassium Plant Foods

When the kidneys are not working well, potassium levels in the blood can rise.

Study: Iron-Based Phosphate Binders Good for Renal Anemia

Study: Iron-Based Phosphate Binders Good for Renal Anemia

By

The medication may represent a new treatment option for dialysis patients, researchers concluded.

Early Death in Dialysis Patients Linked to High Calcium, Phosphorus

Early Death in Dialysis Patients Linked to High Calcium, Phosphorus

By

Investigators found that dialysis patients with serum calcium levels of 10.2 mg/dL or greater had increased risks of premature death.

Dialysis Patients with Hyperphosphatemia May Benefit from Magnesium

Dialysis Patients with Hyperphosphatemia May Benefit from Magnesium

By

Higher magnesium levels in hemodialysis patients with high phosphorus levels were associated with decreased cardiovascular mortality.

Study Reveals Advantages of Non-Calcareous Phosphate Binders

Study Reveals Advantages of Non-Calcareous Phosphate Binders

By

Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.

Ferric Citrate Controls Phosphorus, Cuts ESA Use

Ferric Citrate Controls Phosphorus, Cuts ESA Use

By

Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.

Insulin Resistance Linked to High Phosphorus in Maintenance Hemodialysis (MHD) Patients

Insulin Resistance Linked to High Phosphorus in Maintenance Hemodialysis (MHD) Patients

By

In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.

Higher Phosphorus, Cardiovascular Disease (CVD) Not Linked in Kidney Disease (CKD) Patients

Higher Phosphorus, Cardiovascular Disease (CVD) Not Linked in Kidney Disease (CKD) Patients

By

Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).

Ferric Citrate Phosphate Binder Cuts Hospitalization Rates

Ferric Citrate Phosphate Binder Cuts Hospitalization Rates

By

Rates for infection-, gastrointestinal-, and cardiac-related adverse events are lower than with sevelamer carbonate or calcium acetate.

Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients

Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients

By

Plant-based diet had the lowest urinary phosphorus excretion, whereas an inorganic-based diet had the highest.

Extended Hemodialysis May Improve Phosphate Control

Extended Hemodialysis May Improve Phosphate Control

By

Researchers observe significant decline in serum phosphate levels with 6 hours vs. 4 hours of treatment.

Higher Phosphorus Levels Predict Increased Death Risk in Men

Higher Phosphorus Levels Predict Increased Death Risk in Men

By

No association between phosphorus levels and all-cause mortality in women.

Elevated Phosphorus Levels Raise Risk of Kidney Failure

Elevated Phosphorus Levels Raise Risk of Kidney Failure

By

Every 1 mg/dL increase in serum phosphorus was independently associated with a 36% increased relative risk of kidney failure.

Hyperphosphatemia Raises Coronary Artery Calcification (CAC) Risk in Peritoneal Dialysis

Hyperphosphatemia Raises Coronary Artery Calcification (CAC) Risk in Peritoneal Dialysis

By

Study of coronary artery calcification (CAC) risk also shows serum phosphorus levels associated with nutritional intake and dialysis adequacy.

Ferric Citrate Approved for Phosphorus Control in Chronic Kidney Disease (CKD) Patients

Ferric Citrate Approved for Phosphorus Control in Chronic Kidney Disease (CKD) Patients

By

In addition to reducing serum phosphorus levels to within the recommended range, ferric citrate increases iron stores.

Novel Binder Lowers Phosphate with Fewer Pills

Novel Binder Lowers Phosphate with Fewer Pills

By

In a study, PA21 was as efficacious as sevelamer carbonate, but patients taking PA21 had a lower pill burden and better adherence.

Elevated Phosphorus May Increase Death Risk

Elevated Phosphorus May Increase Death Risk

By

Researchers observed the association among individuals with serum phosphorus levels measured after fasting for 12 or more hours.

Hospitalization Costs Lower with Ferric Citrate

Hospitalization Costs Lower with Ferric Citrate

By

Use is associated with fewer hospitalizations versus sevelamer carbonate and calcium acetate.

Sign Up for Free e-newsletters